You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ABCL Buy Disclosure
Booth Andrew · SEC Form 4 · Filed Aug 14, 2026
Buy
Calculated transaction value
$383.9K
Booth Andrew Chief Financial Officer
ABCL
Transaction date
Aug 14, 2026
Public filing date
Aug 14, 2026
Filing lag
Filed same day
ABCL daily price context
Close on/before transaction
$11.38
Aug 14, 2026
First close after public filing
$11.38
Aug 14, 2026
30-day return after filing
-1.85%
Through Sep 14, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Shares
- Quantity / price
- 37,200 shares @ $10.32
- SEC ownership
- Direct
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001834411-26-000008
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$383.9K
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Abcellera Biologics Inc. ABCL Current | Buy | Aug 14, 2026 | $383.9K |